SCOPUS 정보 검색 플랫폼 - 논문 보기

메뉴 건너뛰기

Clinical Cancer Research

Volumn 7, Issue 5, 2001, Pages 1108-1109

Soluble Fas and cancer

(1) Owen Schaub, L a

a UNIVERSITY OF CALIFORNIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROTEIN BCL 2; PROTEIN BCL X; RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; CANCER CELL; EDITORIAL; MELANOMA; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIGENS, CD95; APOPTOSIS; HUMANS; NEOPLASMS; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0034905623 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Editorial

Times cited : (14)

References (14)

1
- 0034901557
- Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients
- in press
- (2001) Clin. Cancer. Res. , vol.7
- Ugurel, S.¹ Rappl, G.² Tilgen, W.³ Reinhold, U.⁴

2
- 0033523684
- The inhibitor of death receptor signaling. FLICE-inhibitory protein defines a new class of tumor progression factors
- (1999) J. Exp. Med. , vol.190 , pp. 1025-1031
- Djerbi, M.¹ Screpanti, V.² Catrina, A.I.³ Bogen, B.⁴ Biberfeld, P.⁵ Grandien, A.⁶

3
- 0033523670
- Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
- (1999) J. Exp. Med. , vol.190 , pp. 1033-1038
- Medema, J.P.¹ De Jong, J.² Van Hall, T.³ Melief, C.J.M.⁴ Offringa, R.⁵

4
- 0032476609
- Fas and Fas ligand interactions suppress melanoma lung metastasis
- (1998) J. Exp. Med. , vol.188 , pp. 1717-1723
- Owen-Schaub, L.B.¹ Van Golen, K.L.² Hill, L.L.³ Price, J.E.⁴

5
- 0028274042
- Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
- (1994) Science (Wash. DC) , vol.263 , pp. 1759-1762
- Cheng, J.¹ Zhou, T.² Liu, C.³ Shapiro, J.P.⁴ Brauer, M.J.⁵ Kiefer, M.C.⁶ Barr, P.J.⁷ Mountz, J.D.⁸

6
- 0029648996
- Soluble Fas/APO-1 in tumor cells: A potential regulator of apoptosis?
- (1995) Cancer Lett. , vol.94 , pp. 1-8
- Owen-Schaub, L.B.¹ Angelo, L.S.² Radinsky, R.³ Ware, C.F.⁴ Gesner, T.G.⁵ Bartos, D.P.⁶

7
- 0030063193
- Fas/APO-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis
- (1996) J. Immunol. , vol.156 , pp. 13-17
- Cascino, I.¹ Papoff, G.² De Maria, R.³ Testi, R.⁴ Ruberti, G.⁵

8
- 17444424930
- Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
- (1998) Nature (Lond.) , vol.396 , pp. 699-703
- Pitti, R.M.¹ Marsters, S.A.² Lawrence, D.A.³ Roy, M.⁴ Kischkel, F.C.⁵ Dowd, P.⁶ Huang, A.⁷ Donahue, C.J.⁸ Sherwood, S.W.⁹ Baldwin, D.T.¹⁰ Godowski, P.J.¹¹ Wood, W.I.¹² Gurney, A.L.¹³ Hillan, K.J.¹⁴ Cohen, R.L.¹⁵ Goddard, A.D.¹⁶ Botstein, D.¹⁷ Ashkenazi, A.¹⁸

9
- 0029838411
- Elevated soluble Fas (sFas) levels in patients with nonhematopietic malignancies
- (1996) Cancer Res. , vol.56 , pp. 3870-3875
- Midis, G.M.¹ Chen, Y.² Owen-Schaub, L.B.³

10
- 0031783087
- Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma
- (1998) Clin. Exp. Immunol. , vol.112 , pp. 166-171
- Jodo, S.¹ Kobayashi, S.² Nakajima, Y.³ Matsunaga, T.⁴ Nakayama, N.⁵ Ogura, N.⁶ Kayagaki, N.⁷ Okumura, K.⁸ Koike, T.⁹

11
- 0032323358
- Prognostic significance of soluble Fas in the serum of patients with bladder cancer
- (1998) J. Urol. , vol.160 , pp. 571-576
- Mizutani, Y.¹ Yoshida, O.² Bonavida, B.³

12
- 0032737486
- Circulating soluble Fas concentration in breast cancer patients
- (1999) Clin. Cancer Res. , vol.5 , pp. 3529-3533
- Ueno, T.¹ Toi, M.² Tominaga, T.³

13
- 0034034661
- Serum soluble Fas levels in ovarian cancer
- (2000) Obstet. Gynecol. , vol.96 , pp. 65-69
- Hefler, L.¹ Mayerhofer, K.² Nardi, A.³ Reinthaller, A.⁴ Kainz, C.⁵ Tempfer, C.⁶

14
- 0033954428
- Soluble Fas in serum from patients with renal cell carcinoma
- (2000) Urology , vol.55 , pp. 151-155
- Nonomura, N.¹ Nishimura, K.² Ono, Y.³ Harada, Y.⁴ Takahra, N.⁵ Takahara, S.⁶ Okuyama, A.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.